已批准的类固醇药物 (2000-2025):医学化学的视角
Jiacheng Zhu1, Guoshun Luo1, Hua Xiang1
1State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, P. R. China.
类固醇药物是医学中使用的重要生物分子. 本综述详细介绍了2000-2025年期间批准的23种类固醇药物,用于治疗各种疾病,包括与性别有关的,炎症性,神经和心血管疾病.
科学领域:
- 生物化学和药理学 生物化学和药理学
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- 类固醇是具有各种自然作用的关键生物分子.
- 类固醇支架是许多治疗剂的基础.
- 在类固醇药物开发方面取得了重大进展.
研究的目的:
- 综合审查2000年至2025年间批准的类固醇药物.
- 根据机械和治疗领域对这些药物进行分类.
- 突出结构-活性关系和对未来药物开发的临床意义.
主要方法:
- 从2000年到2025年批准的类固醇药物的系统审查.
- 根据四个关键治疗领域进行分类:与性别相关的,炎症性,神经和心血管/代谢疾病.
- 分析生理作用,受体结合,结构-活性关系和临床影响.
主要成果:
- 23种类固醇药物获得了治疗,诊断或生殖健康应用的初步批准.
- 药物被分为与性别相关的疾病,炎症性疾病,神经系统疾病和心血管/代谢疾病.
- 强调受体结合,SAR和这些类固醇治疗药物的临床相关性.
结论:
- 类固醇药物继续在现代医学中发挥关键作用.
- 了解它们的机制和SAR是未来治疗创新的关键.
- 本综述为开发新型类固醇疗法提供了战略概述.
更多相关视频
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
06:26Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
相关概念视频
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drug Classes and Categories
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Products: Biologics, Biosimilars and Interchangeables
